Francisco Sotomayor-Lugo

Dr. Francisco Sotomayor-Lugo

Molecular Biology Laboratory, Abu Dhabi Stem Cells Center, Abu Dhabi, Abū Z̧aby, United Arab Emirates
orcid
Research Scientist

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Francisco Sotomayor-LugoFrancisco Sotomayor-Lugo
Francisco Sotomayor-Lugo
NINataly Iglesias-Barrameda
Nataly Iglesias-Barrameda
Yandy Marx Castillo AlemanYandy Marx Castillo Aleman
Yandy Marx Castillo Aleman
IHImilla Casado Hernandez
Imilla Casado Hernandez
CVCarlos Agustin Villegas-Valverde
Carlos Agustin Villegas-Valverde
RENE ANTONIO RIVERO JIMENEZRENE ANTONIO RIVERO JIMENEZ
RENE ANTONIO RIVERO JIMENEZ
Mammalian fertilization initiates the reprogramming of oocytes and sperm, forming a totipotent zygote. During this intricate process, the zygotic genome undergoes a maternal-to-zygotic transition (MZT) and subsequent zygotic genome activation (ZGA), marking the initiation of transcriptional control and gene expression post-fertilization. Histone modifications are pivotal in shaping cellular identity and gene expression in many mammals. Recent advances in chromatin analysis have enabled detailed explorations of histone modifications during ZGA. This review delves into conserved and unique regulatory strategies, providing essential insights into the dynamic changes in histone modifications and their variants during ZGA in mammals. The objective is to explore recent advancements in leading mechanisms related to histone modifications governing this embryonic development phase in depth. These considerations will be useful for informing future therapeutic approaches that target epigenetic regulation in diverse biological contexts. It will also contribute to the extensive areas of evolutionary and developmental biology and possibly lay the foundation for future research and discussion on this seminal topic.

7 March 2022 in Egyptian Journal of Medical Human Genetics
Verified
Journal Article
Open access
PDF file
Francisco Sotomayor-LugoFrancisco Sotomayor-Lugo
Francisco Sotomayor-Lugo
CAClaudia Alemañy
Claudia Alemañy
HRHilda Roblejo
Hilda Roblejo
YZYaíma Zúñiga-Rosales
Yaíma Zúñiga-Rosales
GMGiselle Monzón-Benítez
Giselle Monzón-Benítez
BMBeatriz Marcheco-Teruel
Beatriz Marcheco-Teruel
Background: Tumor necrosis factor-alpha (TNFɑ) is a cytokine that manages the host defense mechanism, which may play a role in the pathogenesis of COVID-19 patients. Several single-nucleotide polymorphisms, described in the promoter region of the TNFα gene, have a significant role on its transcriptional activity. These include the − 308A > G polymorphism which increases the TNFα levels with the expression of the A allele. The aim of this study was to explore whether the TNFα.− 308A > G polymorphism affects the clinical state of COVID-19 patients. The study included a total of 1028 individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which were distributed in 3 groups: asymptomatic, mild symptomatic and severe symptomatic patients. The amplification-refractory mutation system was used to determine the genotype of the TNFα.− 308A > G polymorphism.Results: Results show a higher tendency of being asymptomatic in individuals carrying the GG genotype (336 of 411; OR 1.24, 95% CI 0.91–1.70). The development of a severe form of SARS-CoV-2 infection was not found in subjects with the A allele compared to those with the G allele (OR 0.96, 95% CI 0.51–1.79), except in the eastern region of the country where the risk increased (OR 4.41, 95% CI 1.14–17.05). However, the subjects carrying the A allele had a higher chance of developing symptoms (OR 1.24, 95% CI 0.91–1.70) compared to those with the G allele.Conclusion: The TNFα.− 308A allele has an influence on developing symptoms of COVID-19 in Cuban patients, and that it particularly increases the risk of presenting severe forms of the disease in the eastern region of the country.

16 May 2022 in MEDICC Review
Verified
Journal Article
Open access
NPNayade Pereira-Roche
Nayade Pereira-Roche
HRHilda Roblejo
Hilda Roblejo
LMLilia C. Marín-Padrón
Lilia C. Marín-Padrón
RIRodolfo Izaguirre-Rodríguez
Rodolfo Izaguirre-Rodríguez
Francisco Sotomayor-LugoFrancisco Sotomayor-Lugo
Francisco Sotomayor-Lugo
BMBeatriz Marcheco-Teruel
Beatriz Marcheco-Teruel
INTRODUCTION COVID-19 sequelae, or the short-, medium-, and long-term manifestations of the disease are under continuous study. There are currently few reports on the evolution of hematological variables following a demonstrated absence of SARS-CoV-2 after infection. OBJECTIVE Identify hematological alterations in Cuban adults recovered from SARS-CoV-2 infection, and their relation with disease severity. METHODS We […]

3 January 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Francisco Sotomayor-LugoFrancisco Sotomayor-Lugo
Francisco Sotomayor-Lugo
NINataly Iglesias-Barrameda
Nataly Iglesias-Barrameda
Yandy Marx Castillo AlemanYandy Marx Castillo Aleman
Yandy Marx Castillo Aleman
IHImilla Casado Hernandez
Imilla Casado Hernandez
CVCarlos Agustin Villegas-Valverde
Carlos Agustin Villegas-Valverde
RENE ANTONIO RIVERO JIMENEZRENE ANTONIO RIVERO JIMENEZ
RENE ANTONIO RIVERO JIMENEZ
Mammalian fertilization initiates the reprogramming of oocytes and sperm, leading to the formation of a totipotent zygote. The zygotic genome remains transcriptionally silent throughout this intricate process, undergoing the maternal-to-zygotic transition (MZT) and subsequent zygotic genome activation (ZGA). Histone modifications are pivotal in shaping cellular identity and gene expression in many mammals. Recent advances in chromatin analysis enable a detailed exploration of histone modifications during ZGA. This review delves into conserved and unique regulatory strategies, providing essential insights into the dynamic changes in histone modifications and their variants during ZGA in mammals. The objective is to explore recent advancements in leading mechanisms related to histone modifications governing this embryonic development phase in depth. These considerations will be useful for informing future therapeutic approaches that target epigenetic regulation in diverse biological contexts, ranging from regenerative medicine to cancer research. It will also contribute to the extensive areas of evolutionary and developmental biology and possibly lay the foundation for future research and discussion on this seminal topic.

12 April 2022 in Immunobiology
Verified
Journal Article
Closed access
BRBárbara Torres Rives
Bárbara Torres Rives
YRYaíma Zúñiga Rosales
Yaíma Zúñiga Rosales
MVMinerva Mataran Valdés
Minerva Mataran Valdés
HBHilda Roblejo Balbuena
Hilda Roblejo Balbuena
GTGoitybell Martínez Téllez
Goitybell Martínez Téllez
BTBeatriz Marcheco Teruel
Beatriz Marcheco Teruel

1 January 2024 in Case Reports in Immunology
Verified
Journal Article
Open access
Yandy Marx Castillo AlemanYandy Marx Castillo Aleman
Yandy Marx Castillo Aleman
Francisco Sotomayor-LugoFrancisco Sotomayor-Lugo
Francisco Sotomayor-Lugo
SSSherjeel Sana
Sherjeel Sana
NANameer Abdul Raheem Kadhum Al-Saadawi
Nameer Abdul Raheem Kadhum Al-Saadawi
YVYendry Ventura-Carmenate
Yendry Ventura-Carmenate
DGDavid Grossman
David Grossman
X‐linked moesin‐associated immunodeficiency (X‐MAID) is a recently identified combined immunodeficiency caused by a mutation in the moesin (MSN) gene. It is characterized by cytopenias, hypogammaglobulinemia, poor immune response to vaccine antigens, and increased susceptibility to early‐life infections. We report a patient with adult‐onset neutropenia, lymphopenia, inadequate response to the pneumococcal polysaccharide vaccine (PPSV23), and recurrent bacterial infections associated with a hemizygous MSN deletion. Notably, the patient has no history of significant childhood infections, cytopenias, or hypogammaglobulinemia. Although only a few cases have been documented worldwide, we underscore the importance of whole‐genome sequencing (WES) in diagnosing this atypical immunodeficiency disease in adulthood. Moreover, this report may shed light on our understanding of further variants of X‐MAID and enrich the known spectrum of the disease.